Seres Therapeutics Inc (NASDAQ:MCRB)

9.21
Delayed Data
As of Nov 26
 -0.46 / -4.76%
Today’s Change
5.41
Today|||52-Week Range
29.93
-62.41%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Seres Therapeutics Inc have a median target of 16.00, with a high estimate of 32.00 and a low estimate of 7.00. The median estimate represents a +73.72% increase from the last price of 9.21.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Seres Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.49
Sales
$5.7M
Reporting Date
Mar 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -167.71%
 
 
 
 
 
 
Growthannually 40.40%
 
 
 
 
 
 

Sales

Growthquarterly -95.52%
 
 
 
 
 
 
Growthannually 331.21%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.